CA Stock MarketDetailed Quotes

XRTX XORTX Therapeutics Inc

Watchlist
  • 1.700
  • +0.020+1.19%
15min DelayMarket Closed Aug 23 16:00 ET
4.94MMarket Cap-3359P/E (TTM)

XORTX Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-50.06%3.08M
-51.50%3.84M
-66.96%3.45M
-66.96%3.45M
-42.99%5.07M
-40.82%6.16M
-36.34%7.91M
-29.83%10.43M
-29.83%10.43M
126.94%8.89M
-Cash and cash equivalents
-50.06%3.08M
-51.50%3.84M
-66.96%3.45M
-66.96%3.45M
-42.99%5.07M
-40.82%6.16M
-36.34%7.91M
-29.83%10.43M
-29.83%10.43M
126.94%8.89M
-Accounts receivable
-25.01%22.81K
-15.21%30.88K
-25.74%60.71K
-25.74%60.71K
7.83%68.24K
-84.28%30.41K
-70.81%36.42K
101.09%81.75K
101.09%81.75K
--63.28K
Current deferred assets
--48.1K
2,429.74%157.1K
--323.44K
--323.44K
----
----
--6.21K
--0
--0
-7.72%449.55K
Total current assets
-47.37%3.36M
-43.23%4.66M
-62.66%4.07M
-62.66%4.07M
-44.81%5.23M
-41.35%6.38M
-38.16%8.21M
-31.53%10.9M
-31.53%10.9M
59.17%9.47M
Non current assets
-Accumulated depreciation
-108.25%-161.14K
-127.36%-134.25K
-178.45%-114.01K
-178.45%-114.01K
-317.13%-95.71K
-1,218.12%-77.38K
---59.05K
---40.94K
---40.94K
---22.94K
-Long term equity investment
----
----
--0
--0
--0
--0
--0
--11.51K
--11.51K
--28.24K
-Goodwill
4.03%168.91K
-1.28%165.99K
-12.30%175.25K
-12.30%175.25K
-9.91%171.52K
-19.12%162.36K
-17.61%168.15K
-1.13%199.83K
-1.13%199.83K
-0.45%190.39K
-Other intangible assets
-41.86%5.59M
-42.13%5.55M
-11.72%5.49M
-11.72%5.49M
89.49%9.64M
78.78%9.61M
83.94%9.58M
24.03%6.22M
24.03%6.22M
335.67%5.09M
Regulatory assets
-25.01%22.81K
-15.21%30.88K
-25.74%60.71K
-25.74%60.71K
7.83%68.24K
-84.28%30.41K
-70.81%36.42K
101.09%81.75K
101.09%81.75K
-95.63%63.28K
Non current deferred assets
0.00%1.2M
0.00%1.2M
1.19%1.2M
1.19%1.2M
2.16%1.2M
-3.74%1.2M
-6.73%1.2M
-6.40%1.19M
-6.40%1.19M
--1.17M
Liabilities
Current liabilities
Current debt and capital lease obligation
85.25%83.71K
-77.19%14.04K
-82.58%11.51K
-82.58%11.51K
-55.60%28.51K
-32.40%45.19K
--61.54K
--66.09K
--66.09K
--64.21K
-Current capital lease obligation
85.25%83.71K
-77.19%14.04K
-82.58%11.51K
-82.58%11.51K
-55.60%28.51K
-32.40%45.19K
--61.54K
--66.09K
--66.09K
--64.21K
-accounts payable
13.67%269.98K
-56.07%185.07K
-84.87%195.81K
-84.87%195.81K
-59.45%394.03K
-58.82%237.51K
-28.18%421.25K
299.37%1.29M
299.37%1.29M
93.33%971.72K
-Total tax payable
--1.57M
--3.22M
-86.26%531K
-86.26%531K
--0
--0
--0
6.61%3.87M
6.61%3.87M
--1.69M
Current accrued expenses
39.31%167.96K
21.21%141.83K
-42.13%87.61K
-42.13%87.61K
-65.94%131.21K
-6.15%120.57K
18.18%117.01K
-33.88%151.41K
-33.88%151.41K
549.05%385.27K
Current liabilities
29.36%521.64K
-43.16%340.93K
-80.48%294.94K
-80.48%294.94K
-61.04%553.76K
-47.77%403.26K
-12.51%599.79K
173.32%1.51M
173.32%1.51M
-84.98%1.42M
Non current liabilities
-Long term debt
----
----
--0
--0
--0
--0
--0
--11.51K
--11.51K
--28.24K
Non current accrued expenses
21.86%73.79K
-71.32%22.15K
-74.18%23.93K
-74.18%23.93K
-59.73%42.23K
-53.17%60.55K
--77.25K
--92.68K
--92.68K
--104.85K
Derivative product liabilities
--1.57M
--3.22M
-86.22%531K
-86.22%531K
--0
--0
--0
6.29%3.85M
6.29%3.85M
--1.66M
Total non current liabilities
419.43%2.09M
493.46%3.56M
-84.64%825.94K
-84.64%825.94K
-82.20%553.76K
-86.33%403.26K
-85.15%599.79K
28.66%5.38M
28.66%5.38M
-67.13%3.11M
Shareholders'equity
Share capital
4.77%17.87M
4.78%17.87M
3.22%17.06M
3.22%17.06M
16.58%17.06M
9.84%17.06M
6.42%17.06M
2.71%16.52M
2.71%16.52M
42.94%14.63M
-common stock
4.77%17.87M
4.78%17.87M
3.22%17.06M
3.22%17.06M
16.58%17.06M
9.84%17.06M
6.42%17.06M
2.71%16.52M
2.71%16.52M
42.94%14.63M
Gains losses not affecting retained earnings
0.00%-52.61K
0.00%-52.61K
0.00%-52.61K
0.00%-52.61K
---52.61K
---52.61K
---52.61K
-169.64%-52.61K
-169.64%-52.61K
----
Total equity
-38.48%4.8M
-37.36%6.05M
-55.81%5.47M
-55.81%5.47M
-39.30%6.64M
-37.35%7.8M
-34.61%9.66M
-28.81%12.37M
-28.81%12.37M
78.15%10.94M
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -50.06%3.08M-51.50%3.84M-66.96%3.45M-66.96%3.45M-42.99%5.07M-40.82%6.16M-36.34%7.91M-29.83%10.43M-29.83%10.43M126.94%8.89M
-Cash and cash equivalents -50.06%3.08M-51.50%3.84M-66.96%3.45M-66.96%3.45M-42.99%5.07M-40.82%6.16M-36.34%7.91M-29.83%10.43M-29.83%10.43M126.94%8.89M
-Accounts receivable -25.01%22.81K-15.21%30.88K-25.74%60.71K-25.74%60.71K7.83%68.24K-84.28%30.41K-70.81%36.42K101.09%81.75K101.09%81.75K--63.28K
Current deferred assets --48.1K2,429.74%157.1K--323.44K--323.44K----------6.21K--0--0-7.72%449.55K
Total current assets -47.37%3.36M-43.23%4.66M-62.66%4.07M-62.66%4.07M-44.81%5.23M-41.35%6.38M-38.16%8.21M-31.53%10.9M-31.53%10.9M59.17%9.47M
Non current assets
-Accumulated depreciation -108.25%-161.14K-127.36%-134.25K-178.45%-114.01K-178.45%-114.01K-317.13%-95.71K-1,218.12%-77.38K---59.05K---40.94K---40.94K---22.94K
-Long term equity investment ----------0--0--0--0--0--11.51K--11.51K--28.24K
-Goodwill 4.03%168.91K-1.28%165.99K-12.30%175.25K-12.30%175.25K-9.91%171.52K-19.12%162.36K-17.61%168.15K-1.13%199.83K-1.13%199.83K-0.45%190.39K
-Other intangible assets -41.86%5.59M-42.13%5.55M-11.72%5.49M-11.72%5.49M89.49%9.64M78.78%9.61M83.94%9.58M24.03%6.22M24.03%6.22M335.67%5.09M
Regulatory assets -25.01%22.81K-15.21%30.88K-25.74%60.71K-25.74%60.71K7.83%68.24K-84.28%30.41K-70.81%36.42K101.09%81.75K101.09%81.75K-95.63%63.28K
Non current deferred assets 0.00%1.2M0.00%1.2M1.19%1.2M1.19%1.2M2.16%1.2M-3.74%1.2M-6.73%1.2M-6.40%1.19M-6.40%1.19M--1.17M
Liabilities
Current liabilities
Current debt and capital lease obligation 85.25%83.71K-77.19%14.04K-82.58%11.51K-82.58%11.51K-55.60%28.51K-32.40%45.19K--61.54K--66.09K--66.09K--64.21K
-Current capital lease obligation 85.25%83.71K-77.19%14.04K-82.58%11.51K-82.58%11.51K-55.60%28.51K-32.40%45.19K--61.54K--66.09K--66.09K--64.21K
-accounts payable 13.67%269.98K-56.07%185.07K-84.87%195.81K-84.87%195.81K-59.45%394.03K-58.82%237.51K-28.18%421.25K299.37%1.29M299.37%1.29M93.33%971.72K
-Total tax payable --1.57M--3.22M-86.26%531K-86.26%531K--0--0--06.61%3.87M6.61%3.87M--1.69M
Current accrued expenses 39.31%167.96K21.21%141.83K-42.13%87.61K-42.13%87.61K-65.94%131.21K-6.15%120.57K18.18%117.01K-33.88%151.41K-33.88%151.41K549.05%385.27K
Current liabilities 29.36%521.64K-43.16%340.93K-80.48%294.94K-80.48%294.94K-61.04%553.76K-47.77%403.26K-12.51%599.79K173.32%1.51M173.32%1.51M-84.98%1.42M
Non current liabilities
-Long term debt ----------0--0--0--0--0--11.51K--11.51K--28.24K
Non current accrued expenses 21.86%73.79K-71.32%22.15K-74.18%23.93K-74.18%23.93K-59.73%42.23K-53.17%60.55K--77.25K--92.68K--92.68K--104.85K
Derivative product liabilities --1.57M--3.22M-86.22%531K-86.22%531K--0--0--06.29%3.85M6.29%3.85M--1.66M
Total non current liabilities 419.43%2.09M493.46%3.56M-84.64%825.94K-84.64%825.94K-82.20%553.76K-86.33%403.26K-85.15%599.79K28.66%5.38M28.66%5.38M-67.13%3.11M
Shareholders'equity
Share capital 4.77%17.87M4.78%17.87M3.22%17.06M3.22%17.06M16.58%17.06M9.84%17.06M6.42%17.06M2.71%16.52M2.71%16.52M42.94%14.63M
-common stock 4.77%17.87M4.78%17.87M3.22%17.06M3.22%17.06M16.58%17.06M9.84%17.06M6.42%17.06M2.71%16.52M2.71%16.52M42.94%14.63M
Gains losses not affecting retained earnings 0.00%-52.61K0.00%-52.61K0.00%-52.61K0.00%-52.61K---52.61K---52.61K---52.61K-169.64%-52.61K-169.64%-52.61K----
Total equity -38.48%4.8M-37.36%6.05M-55.81%5.47M-55.81%5.47M-39.30%6.64M-37.35%7.8M-34.61%9.66M-28.81%12.37M-28.81%12.37M78.15%10.94M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg